Cargando…
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
Breast cancer is the most commonly diagnosed cancer worldwide and ranks first in terms of both prevalence and cancer-related mortality in women. In this study, we aimed to evaluate the anticancer effect of mebendazole (MBZ) and radiotherapy (RT) concomitant use in triple-negative breast cancer (TNBC...
Autores principales: | Choi, Hoon Sik, Ko, Young Shin, Jin, Hana, Kang, Ki Mun, Ha, In Bong, Jeong, Hojin, Lee, Jeong-hee, Jeong, Bae Kwon, Kim, Hye Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779603/ https://www.ncbi.nlm.nih.gov/pubmed/36555137 http://dx.doi.org/10.3390/ijms232415493 |
Ejemplares similares
-
Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
por: Choi, Hoon Sik, et al.
Publicado: (2021) -
Role of radiotherapy in the management of malignant airway obstruction
por: Choi, Hoon Sik, et al.
Publicado: (2020) -
Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1
por: Choi, Hoon Sik, et al.
Publicado: (2021) -
Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model
por: Song, Haa-Na, et al.
Publicado: (2021) -
Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis
por: Choi, Hoon Sik, et al.
Publicado: (2020)